Cody Parsons, APh, PharmD, BCCCP, explains how the AHA's 40-hospital collaborative is mapping care gaps for patients with HFpEF and HFmrEF.
|Articles|September 1, 2003
- Volume 0 0
Free Directory for Seniors
Advertisement
The National Institute on Aging and the Administration on Aging have compiled a ?Resource Directory for Older People.? This free resource lists ~300 public and private organizations, complete with mailing addresses and telephone numbers as well as Internet and e-mail addresses. The directory answers questions on a range of topics, including physical fitness, nursing homes, Alzheimer?s disease, and support groups. For a copy, call 800-222-2225 or TTY 800-222-4225; ask for Department RD.
Articles in this issue
about 23 years ago
Warning: West Nile Risk Higher for Seniorsabout 23 years ago
Seniors Accentuate the Positiveabout 23 years ago
Seniors Accentuate the Positiveabout 23 years ago
Mind Games Fuel the Mindabout 23 years ago
Breast-Feeding Reduces Harm of Smoking in Pregnancyabout 23 years ago
Race Factors into Breast Cancer Treatmentabout 23 years ago
Females Are the Tougher Sexabout 23 years ago
Assisted Reproduction and Miscarriage Rateabout 23 years ago
Cocaine Addiction Therapy Reduces HIV Riskabout 23 years ago
Tips for "When Johnny Comes Marching Home"Advertisement
Related to this article
Experts highlighted how Diamond-Blackfan anemia illustrates the scientific, financial, and manufacturing challenges that can prevent promising gene therapies for ultra-rare diseases from reaching patients.
Experts highlighted recent gene therapy approvals for inherited immune disorders while addressing ongoing challenges in manufacturing, long-term safety, and patient access.
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
At the 2026 ASTCT Gene Therapy Summit, experts highlighted how chronic pain, psychological challenges, and neurologic complications may persist despite successful treatment.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
ADA guidance ties monitoring choices to therapy, risk, and preference. Brooke Hudspeth, PharmD, explains how pharmacists help individualize the plan.
Twice-daily metronidazole dosing had outcomes comparable with those of thrice-daily dosing for confirmed anaerobic infections, minimizing drug exposure and cost while maintaining clinical efficacy.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CVS Health to Split Into 2 Public Companies, Separating Retail and Specialty Pharmacy
2
Two Gene Therapy Approvals Expand Options for Rare Immune Disorders as Access Challenges Persist
3
Is Less More? Comparing Metronidazole Dosing in Confirmed Anaerobic Infections
4
RSV Hospitalization Linked to Higher Short-Term Risk of Invasive Pneumococcal Disease
5